Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier.
Viruses have evolved the ability to bind and enter cells through interactions with a wide variety of cell macromolecules. We engineered peptide-modified adeno-associated virus (AAV) capsids that transduce the brain through the introduction of de novo interactions with 2 proteins expressed on the mou...
Autori principali: | , , , , , , , , , , , , , , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Public Library of Science (PLoS)
2023-07-01
|
Serie: | PLoS Biology |
Accesso online: | https://doi.org/10.1371/journal.pbio.3002112 |